Relay Therapeutics Inc is trading 4.2% up today at $14.09 as shares stage a technical rebound following last week's sharp biotech weakness tied to higher-rate expectations.
- The upward move appears primarily technical, as broader risk-on sentiment lifts growth and biotech names despite no new company-specific developments.
- The stock continues to trade well above its recent upsized public offering price of $12.00 per share.
- The recovery follows a period of volatility driven by shifting macroeconomic expectations impacting the broader sector.